The durability of weight loss effects has been examined in the SURMOUNT-4 trial (Rubino et al., JAMA 2023), which demonstrated that discontinuation of tirzepatide after successful weight loss led to significant weight regain, suggesting ongoing treatment may be necessary for sustained benefits
We offer national telehealth consultations, allowing eligible clients to access GLP-1 care from home with licensed provider oversight
As you continue with the treatment, the appetite-suppressing effects become more pronounced, making it easier to reduce food intake and stick to a healthier eating plan
Mice were individually brought from the colony room to the behavioral room for the start of each behavioral test
CVS Caremark will add Zepbound back to our commercial formularies as an additional preferred option October 1, 2026, increasing access to GLP-1s at a more affordable price for plan sponsors who elect to provide coverage of those medications for their members
Ivy Rx We compared pricing, bilingual support, licensing, and care across both platforms including where Ivy Rx advertises a lower headline price